InvestorsHub Logo
Followers 0
Posts 798
Boards Moderated 0
Alias Born 07/27/2018

Re: boston745 post# 18971

Tuesday, 09/11/2018 3:47:11 PM

Tuesday, September 11, 2018 3:47:11 PM

Post# of 41362
K2M was projected to surpass Stryker in sales somewhere. They where both looking toward titanium 3d printing. If these scout ship relationships do exist, then Osseus is a Zimmer 3d printing Ti hovering over Dallas. https://www.osseus.com/aries-lumbar-ibfd/

"The proprietary lattice" Not sure if small enough but there was a research study into ceramics flexing not breaking with a similar construction.

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K172788

Not sure what the Monet system is out of CTL. Predicative was the Mattisse. CTL doesnt appear to be doing anything with 3d printing. As far as CTL competing against OSSEUS. this is great news for CTL. I would switch out the Ti peek in Mattisse for Si Ni doped Peek at least if not switch Ti to Si Ni. Unfortunately Osseus looks to be the better Suit for amedica, pure tech.Doing everything CTL does, More and prettier. No clue on sales ability, where it matters. You have to pay to play with these docs. Prob. Not so much VA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News